Utah Medical Products (UTMD) Cash Flow: Operating & Free Cash Flow

Utah Medical Products (UTMD) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Utah Medical Products generated $14.69M of operating cash flow and spent $371.00K on capital expenditures. That left free cash flow of $14.32M, down 1.9% from $14.60M a year earlier, or 37.2% of revenue. It returned $12.34M to shareholders through $3.98M in dividends and $8.36M in share buybacks.

Utah Medical Products Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Utah Medical Products, Inc. (UTMD) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	11.29	13.87	16.64	16.47	14.79	10.80	14.73	18.56	8.51
Depreciation & Amortization	3.01	2.85	6.37	7.08	7.28	7.21	6.88	2.96	2.77
Deferred Income Tax	-0.66	-0.34	-0.68	-0.40	-0.05	-0.03	-0.40	-0.33	-0.66
Stock Based Compensation	0.37	0.26	0.23	0.18	0.17	0.16	0.11	0.06	0.13
Change in Working Capital	0.32	-1.80	-0.23	-2.23	-1.01	1.99	-4.32	-4.04	6.14
Change in Accounts Receivable	0.33	-0.78	2.27	-0.53	-1.13	0.66	-0.74	-0.50	-0.24
Change in Inventory	1.20	0.59	-0.67	-2.35	-0.49	0.92	-1.69	-0.24	-0.47
Change in Accounts Payable	0.21	-0.07	-0.46	0.46	-0.02	-0.31	0.11	0.05	0.01
Change in Other Working Capital	-1.42	-0.03	-1.38	0.19	-0.08	0.72	-2.01	-3.35	6.84
Other Operating Activities	0.37	-0.34	-0.03	0.04	-0.03	0.00	0.05	-0.37	0.02
Net Cash from Operating Activities	14.69	14.83	22.28	21.15	21.20	20.14	17.06	16.83	16.91
Investing Activities
Capital Expenditures	-0.37	-0.23	-0.64	-0.82	-0.55	-0.86	-21.54	-0.40	-1.60
Sales/Maturities of Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.00
Other Investing Activities	0.00	0.03	0.00	-0.01	0.00	0.00	-21.00	0.86	0.00
Net Cash from Investing Activities	-0.37	-0.21	-0.64	-0.82	-0.55	-0.86	-21.54	0.53	-1.60
Financing Activities
Common Stock Issued	0.00	0.39	0.00	0.00	0.56	0.00	0.00	0.00	0.38
Common Stock Repurchased	-8.36	-19.97	0.00	-2.50	0.00	-6.98	-0.40	-1.21	-2.85
Dividends Paid	-3.98	-4.26	-4.28	-3.16	-11.47	-4.12	-4.11	-4.03	-2.96
Other Financing Activities	0.00	0.39	0.12	0.17	0.56	0.36	0.28	0.45	0.30
Net Cash from Financing Activities	-12.34	-23.84	-4.17	-5.48	-10.91	-10.73	-4.23	-4.78	-2.65
Summary
Effect of Forex Changes on Cash	0.80	-0.68	0.34	-0.77	-0.36	0.26	0.39	-1.35	0.92
Net Change in Cash	2.78	-9.89	17.82	14.08	9.75	8.80	-8.33	11.24	13.58
Cash at Beginning of Period	82.98	92.87	75.05	60.97	51.59	42.79	51.11	39.88	26.30
Cash at End of Period	85.76	82.98	92.87	75.05	60.97	51.59	42.79	51.11	39.88
Free Cash Flow	14.32	14.60	21.64	20.33	20.65	19.28	-4.48	16.43	15.31
Supplemental Disclosures
Income Taxes Paid	-	4.64	4.83	4.97	4.62	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions About Utah Medical Products Cash Flow

What is Utah Medical Products's free cash flow?

Utah Medical Products generated free cash flow of $14.32M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $14.69M minus $371.00K of capital expenditures. That was down 1.9% from $14.60M a year earlier. Free cash flow equaled 37.2% of revenue.

How much does Utah Medical Products spend on capital expenditures?

Utah Medical Products spent $371.00K on capital expenditures in fiscal 2025, compared with $230.00K a year earlier. That equals 2.5% of operating cash flow.

Does Utah Medical Products pay dividends or buy back shares?

Yes. In fiscal 2025 Utah Medical Products returned $3.98M in dividends and $8.36M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition